Turkish Journal of Internal Medicine (Jul 2020)

A case report of cutaneous and systemic lupus erythematosus after bupropion usage

  • Abdulmecit Yildiz,
  • Mehmet Aydın,
  • Saide Güllülü,
  • Kamil Dilek,
  • Oktay Ünsal,
  • Alparslan Ersoy,
  • Mahmut Yavuz,
  • Mustafa Güllülü,
  • Suat Akgür,
  • Ayşegül Oruç

DOI
https://doi.org/10.46310/tjim.679421
Journal volume & issue
Vol. 2, no. 3
pp. 91 – 94

Abstract

Read online

Bupropion is a drug used to smoke cessation. Various complications have been reported after using this drug. In a 58-year-old female patient, skin findings and anti-Ro52 positivity developed after the use of this drug. Later, signs of vasculitis appeared under immunosuppressive therapy. The patient was diagnosed with cutaneous and systemic lupus erythematosus.

Keywords